The use of pharmacokinetic analyses incorporating relevant determinants of the infliximab serum concentration can be used to develop a predictive model that will allow optimized dosing for individual patients.
The purpose of this study is to develop a predictive model that will allow optimized dosing of infliximab for individual patients